A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.

Schippinger W, Samonigg H, Schaberl-Moser R, Greil R, Thödtmann R, Tschmelitsch J, Jagoditsch M, Steger GG, Jakesz R, Herbst F, Hofbauer F, Rabl H, Wohlmuth P, Gnant M, Thaler J Br J Cancer. 2007 Oct 22,97(8):1021-7. Epub 2007 Sep 25.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, RГјcklinger E, Samonigg H J Natl Cancer Inst. 2007 Dec 19,99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6,100(3):226.

Planned first efficacy and safety analysis of de-intensified induction with fludarabine, cyclophosphamide plus rituximab (FCR) followed by fludarabine plus rituximab (FR) and remission maintenance therapy with rituximab in previously untreated B-chronic lymphocytic leukemia (B-CLL): The chairos study

Egle, A, Weiss, L, Russ, G, Thoedtmann, R, Pleyer, L, Gastl, G, Thaler, J, Petzer, A, Tinhofer, I, Greil, R BLOOD. 2007, 110(11): 609A-609A.

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R Cancer Treat Rev. 2006 Aug,32(5):377-89. Epub 2006 Jun 21. Review.

IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.

Falkensammer C, Jöhrer K, Gander H, Ramoner R, Putz T, Rahm A, Greil R, Bartsch G, Thurnher M. Cancer Immunol Immunother. 2006 Oct,55(10):1228-37. Epub 2006 Jan 28.

Purine antagonists for chronic lymphocytic leukaemia.

Steurer M, Pall G, Richards S, Schwarzer G, Bohlius J, Greil R. Cochrane Database Syst Rev. 2006 Jul 19,(3):CD004270.

Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature.

Mian M, Rass C, Hutarew G, Kofler B, Fiegl M, Greil R. Leuk Lymphoma. 2006 Aug,47(8):1683-5.

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.

Fiegl M, Falkner A, Hopfinger G, Brugger S, Zabernigg A, Bauer F, Haslbauer F, Demirtas D, Grossschmidt P, Tatzreiter G, Gastl G, Greil R Cancer. 2006 Nov 15,107(10):2408-16.

PKC delta is involved in signal attenuation in CD3+ T cells.

Gruber T, Barsig J, Pfeifhofer C, Ghaffari-Tabrizi N, Tinhofer I, Leitges M, Baier G. Immunology Letters. 2005 Jan 31,96(2): 291-3.

Alemtuzumab is effective in patients with advanced, pretreated B-cell chronic lymphocytic leukemia: A nationwide study of routine use in Austria

Fiegl, M, Falkner, A, Hopfinger, G, Brugger, S, Zabernigg, A, Haslbauer, F, Andel, J, Thaler, J, Fridrik, M, Bauer, F, Mian, M, Tatzreiter, G, Zoier, N, Demirtas, D, Postner, G, Auberger, J, Gastl, G, Greil, R BLOOD. 2005, 106(11): 833A-833A.